Close
4

Seqens Seqens

X

Company profile for Oxeia Biopharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Oxeia Biopharmaceuticals is a clinical-stage biotech company developing new, innovative therapeutics for mild traumatic brain injury (mTBI), known as concussion, and related neuro-metabolic dysfunction. The company has a drug, OXE-103, beginning a Phase 2 clinical trial in the fall of 2020. To date there are few other studies aimed at treating these patients. The U.S. Centers for Disease Control and Prevention estimates that ...
Oxeia Biopharmaceuticals is a clinical-stage biotech company developing new, innovative therapeutics for mild traumatic brain injury (mTBI), known as concussion, and related neuro-metabolic dysfunction. The company has a drug, OXE-103, beginning a Phase 2 clinical trial in the fall of 2020. To date there are few other studies aimed at treating these patients. The U.S. Centers for Disease Control and Prevention estimates that just under three million concussion cases visit U.S. emergency rooms annually. Other studies put the number much higher at five million, with as many as 2.4 million of these with mTBI.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Oxeia Biopharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
9920 Pacific Heights Blvd., Suite 150 San Diego, CA 92121-4361
Telephone
Telephone
Linkedin
Linkedin

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY